Advertisement

Topics

Biocept Announces Closing of $10 Million Public Offering of Common Stock and Warrants

12:29 EDT 19 Oct 2016 | PR Newswire
This article has expired, however you can still download the PDF.
Preview:
SAN DIEGO, Oct. 19, 2016 /PRNewswire/ -- Biocept, Inc. (NASDAQ: BIOC), a molecular diagnostics company commercializing and developing blood-based liquid biopsies to provide information to physicians to improve the diagnosis and treatment of cancer, an...

Other Sources for this Article

NEXT ARTICLE

More From BioPortfolio on "Biocept Announces Closing of $10 Million Public Offering of Common Stock and Warrants"

Quick Search
Advertisement
 

Relevant Topics

Diagnostics
A diagnostic test is any kind of medical test performed to aid in the diagnosis or detection of disease. For example: to diagnose diseases to measure the progress or recovery from disease to confirm that a person is free from disease Clin...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...